Cholesterol, Aβ and Alzheimer's disease

This publication has 26 references indexed in Scilit:

• Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
  BMJ, 2001
• Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
  Proceedings of the National Academy of Sciences, 2001
• Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors
  Archives of Neurology, 2000
• Apolipoprotein E: Far More Than a Lipid Transport Protein
  Annual Review of Genomics and Human Genetics, 2000
• Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
  Nature Genetics, 1997
• Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
  The Lancet, 1997
• Evidence that Aβ42 is the real culprit in alzheimer's disease
  Annals of Neurology, 1995
• Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
  Science, 1994
• Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II)
  Journal of Neurochemistry, 1994
• Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
  Science, 1993